B BIOTICARE
Dead / Abandoned — Abandoned — failure to respond (as of 26 Feb 2026)
What this means for you
This application is over — abandoned 13 Feb 2026. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98657956
- Mark type
- Design + words
- Filed
- 19 Jul 2024
- Abandoned
- 13 Feb 2026
- Attorney of record
- Kelley S. Gordon
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the prevention and treatment of diabetes, hyperglycemia, hypoglycemia, insulin resistance, cardiovascular diseases, weight management, metabolic syndrome, metabolic imbalances, gastrointestinal disorders, and related endocrine and metabolic health conditions; dietetic foodstuffs and dietetic substances, namely, probiotic supplements, dietary supplements, dietary fibers, functional foods, dietetic foods, dietetic beverages, and nutritional bars adapted for medical use; food supplements and nutritional supplements for human beings; medicinal healthcare preparations for the treatment of diabetes, hyperglycemia, hypoglycemia, insulin resistance, cardiovascular diseases, weight management, metabolic syndrome, metabolic imbalances, gastrointestinal disorders, and related endocrine and metabolic health conditions.
- Class 044 — Medical, beauty and agricultural services: Providing medical and healthcare information in the field of diabetes management, hyperglycemia, cardiovascular health, weight management, metabolic health, and gut health; medical consultation and medical services, namely, telemedicine and remote healthcare by health care professionals via telecommunication networks; Health counselling, health screening services, internet-based health care information services, and medical dietic counseling for the treatment and management of diabetes and metabolic conditions; preparation of reports relating to medical matters, and providing medical diagnostic information to patients and medical practitioners relating to medical information and patient treatment plans; medical testing and analysis for diagnostic purposes; provision of information relating to pharmaceuticals, dietary supplements, and food supplements for diabetes management.
Owner
- Caelus Pharmaceuticals B.V., Zegveld, NL
Prosecution history
- 26 Feb 2026 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 26 Feb 2026 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 12 Nov 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 12 Nov 2025 — FINAL REFUSAL E-MAILED
- 12 Nov 2025 — FINAL REFUSAL WRITTEN
- 15 Aug 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 15 Aug 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 15 Aug 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 15 May 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 15 May 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 15 Feb 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 15 Feb 2025 — NON-FINAL ACTION E-MAILED
- 15 Feb 2025 — NON-FINAL ACTION WRITTEN
- 13 Feb 2025 — ASSIGNED TO EXAMINER
- 12 Feb 2025 — NOTICE OF DESIGN SEARCH CODE E-MAILED